Concepedia

Adi Diab

AD

135

Publications

18.2K

Citations

58

H-Index

1948

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Nektar Therapeutics (United States)

Moffitt Cancer Center

Cornell University

Adi Diab is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1948–2024

135

Publications

135

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi et al. · Science · 2017 · 4.4K citations · Full text

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Pei-Ling Chen, Whijae Roh, Alexandre Reuben et al. · Cancer Discovery · 2016 · 971 citations · Full text

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

Whijae Roh, Pei-Ling Chen, Alexandre Reuben et al. · Science Translational Medicine · 2017 · 902 citations · Full text

, , +18

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan et al. · Science · 2021 · 804 citations · Full text

, , +28

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 797 citations · Full text

, , +5

Rows per page

1–5 of 135